Allen Samuel C, Lohani Minisha, Hendershot Kristopher A, Deal Travis R, White Taylor, Dixon Margie D, Pentz Rebecca D
a Department of Hematology and Medical Oncology , Winship Cancer Institute, Emory University School of Medicine , Atlanta , Georgia , USA.
b Philadelphia College of Osteopathic Medicine-GA , Suwanee , Georgia , USA.
AJOB Empir Bioeth. 2018 Apr-Jun;9(2):77-81. doi: 10.1080/23294515.2018.1460633. Epub 2018 Apr 26.
The purpose of this study was to determine whether biospecimen donors believe they should receive compensation. This is the first study to report biospecimen donors' views on compensation and can potentially improve informed consent and recruitment practices.
Researchers asked patients undergoing surgical removal of tissue to donate biological materials to a biobank; the request was made at their presurgical appointment or in the preoperative clinic of the Emory University Hospital. We interviewed 126 biospecimen donors within 30 days post surgery regarding their perspective on compensation for biospecimen donation.
In response to the question "Should you be paid for your participation in the tissue bank?," 95 (95/126, 75%) participants answered "No." Of these, 55 (55/95, 58%) indicated that donating biological materials should be about altruism, not gaining a monetary reward. Only 11 (11/126, 9%) participants unequivocally believed they should receive compensation, while 14 (14/126, 11%) felt entitled to compensation only under specific circumstances. Eleven (11/14) "Depends" participants indicated that donors should only be compensated when researchers perform for-profit research. Responses varied by race and income level, with whites more likely to not feel entitled to compensation and higher income participants more likely to respond "Depends."
The majority of biospecimen donors stated they should not be paid for tissue bank participation. However, a minority believe they should be paid for donating tissue if the tissue is used in revenue-generating projects. These results provide some support for the current biobanking practice of not providing compensation.
本研究的目的是确定生物样本捐赠者是否认为他们应该获得补偿。这是第一项报告生物样本捐赠者对补偿看法的研究,可能会改善知情同意和招募实践。
研究人员要求接受组织手术切除的患者将生物材料捐赠给生物样本库;该请求是在他们术前预约时或在埃默里大学医院的术前诊所提出的。我们在术后30天内采访了126名生物样本捐赠者,询问他们对生物样本捐赠补偿的看法。
对于“你参与组织库应该获得报酬吗?”这个问题,95名(95/126,75%)参与者回答“不”。其中,55名(55/95,58%)表示捐赠生物材料应该是出于利他主义,而不是为了获得金钱奖励。只有11名(11/126,9%)参与者明确认为他们应该获得补偿,而14名(14/126,11%)觉得只有在特定情况下才有资格获得补偿。11名(11/14)“视情况而定”的参与者表示,只有当研究人员进行营利性研究时,捐赠者才应该获得补偿。回答因种族和收入水平而异,白人更有可能认为自己没有资格获得补偿,高收入参与者更有可能回答“视情况而定”。
大多数生物样本捐赠者表示,他们参与组织库不应获得报酬。然而,少数人认为,如果组织用于创收项目,他们捐赠组织应该获得报酬。这些结果为目前生物样本库不提供补偿的做法提供了一些支持。